name: EORTC QLQ-C15-PAL Version 1 Questionnaire Question


name: EORTC QLQ-C30 Version 3 Questionnaire Question


name: BPRS 1988 Version Clinical Classification Question


name: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Palliative Care Version 1.0


name: European Organization for the Research and Treatment of Cancer Quality of Life Questionnaire - Core 30 Version 3.0


name: Diabetes Distress Scale for Adults with Type 1 Diabetes Questionnaire


name: Alert Verbal Painful Unresponsive Scale Clinical Classification


name: Brief Psychiatric Rating Scale 1988 Version Clinical Classification


name: Emory Treatment Resistance Interview for PTSD Clinical Classification


name: EORTC QLQ-C15-PAL Version 1 - Trouble Taking Short Walk Outside


name: EORTC QLQ-C15-PAL Version 1 - Stay in Bed or Chair During the Day


name: EORTC QLQ-C15-PAL Version 1 - Need Help Eating, Dressing, Washing


name: EORTC QLQ-C15-PAL Version 1 - Were You Short of Breath


name: EORTC QLQ-C15-PAL Version 1 - Have You Had Pain


name: EORTC QLQ-C15-PAL Version 1 - Have You Had Trouble Sleeping


name: EORTC QLQ-C15-PAL Version 1 - Have You Lacked Appetite


name: EORTC QLQ-C15-PAL Version 1 - Have You Felt Nauseated


name: EORTC QLQ-C15-PAL Version 1 - Have You Been Constipated


name: EORTC QLQ-C15-PAL Version 1 - Were You Tired


name: EORTC QLQ-C15-PAL Version 1 - Pain Interfere Daily Activities


name: EORTC QLQ-C15-PAL Version 1 - Did You Feel Tense


name: EORTC QLQ-C15-PAL Version 1 - Did You Feel Depressed


name: EORTC QLQ-C15-PAL Version 1 - Rate Your Overall Quality of Life


name: EORTC QLQ-C30 Version 3 - Trouble Doing Strenuous Activities


name: EORTC QLQ-C30 Version 3 - Trouble Taking Long Walk


name: EORTC QLQ-C30 Version 3 - Trouble Taking Short Walk Outside


name: EORTC QLQ-C30 Version 3 - Stay in Bed or Chair During the Day


name: EORTC QLQ-C30 Version 3 - Need Help Eating, Dressing, Washing


name: EORTC QLQ-C30 Version 3 - Limited in Work or Daily Activities


name: EORTC QLQ-C30 Version 3 - Limited Hobbies or Leisure Activities


name: EORTC QLQ-C30 Version 3 - Were You Short of Breath


name: EORTC QLQ-C30 Version 3 - Have You Had Pain


name: EORTC QLQ-C30 Version 3 - Did You Need to Rest


name: EORTC QLQ-C30 Version 3 - Have You Had Trouble Sleeping


name: EORTC QLQ-C30 Version 3 - Have You Felt Weak


name: EORTC QLQ-C30 Version 3 - Have You Lacked Appetite


name: EORTC QLQ-C30 Version 3 - Have You Felt Nauseated


name: EORTC QLQ-C30 Version 3 - Have You Vomited


name: EORTC QLQ-C30 Version 3 - Have You Been Constipated


name: EORTC QLQ-C30 Version 3 - Have You Had Diarrhea


name: EORTC QLQ-C30 Version 3 - Were You Tired


name: EORTC QLQ-C30 Version 3 - Pain Interfere Daily Activities


name: EORTC QLQ-C30 Version 3 - Difficulty Concentrating on Things


name: EORTC QLQ-C30 Version 3 - Did You Feel Tense


name: EORTC QLQ-C30 Version 3 - Did You Feel Irritable


name: EORTC QLQ-C30 Version 3 - Did You Feel Depressed


name: EORTC QLQ-C30 Version 3 - Had Difficulty Remembering Things


name: EORTC QLQ-C30 Version 3 - Condition Interfered Family Life


name: EORTC QLQ-C30 Version 3 - Condition Interfered Social Activities


name: EORTC QLQ-C30 Version 3 - Rate Your Overall Health


name: EORTC QLQ-C30 Version 3 - Rate Your Overall Quality of Life


name: T1-DDS - Not Skilled at Managing Diabetes


name: T1-DDS - I Don't Eat Carefully as I Should


name: T1-DDS - Don't Notice Signs of Hypoglycemia


name: T1-DDS - Discouraged See High Blood Glucose


name: T1-DDS - Family Make Bigger Deal Diabetes


name: T1-DDS - Can't Tell Doctor What on My Mind


name: T1-DDS - Too Much Diabetes Equipment With Me


name: T1-DDS - Family Worry About Hypoglycemia


name: T1-DDS - Don't Check Glucose as I Should


name: T1-DDS - Food and Eating Control My Life


name: T1-DDS - Family Act Like Diabetes Police


name: T1-DDS - Be Perfect With Diabetes Management


name: T1-DDS - Hypoglycemic Event While Driving


name: T1-DDS - Subscale 2: Management Distress


name: T1-DDS - Subscale 3: Hypoglycemia Distress


name: T1-DDS - Subscale 4: Negative Social Perceptions


name: T1-DDS - Subscale 7: Friend/Family Distress


name: BPRS 1988 Version - Emotional Withdrawal


name: BPRS 1988 Version - Conceptual Disorganization


name: BPRS 1988 Version - Mannerisms and Posturing


name: BPRS 1988 Version - Hallucinatory Behavior


name: BPRS 1988 Version - Unusual Thought Content


name: Basic Reversed-Phase Liquid Chromatography


name: pH 7.5 Basic Reversed-Phase Liquid Chromatography


name: 2-Dimensional Reversed-Phase Liquid Chromatography


name: Peripheral T-cell Lymphoma Prognostic Index Score


name: Peripheral T-cell Lymphoma Prognostic Index Score 0


name: Peripheral T-cell Lymphoma Prognostic Index Score 1


name: Immobilized Metal Affinity Chromatography with Phosphopeptide Enrichment


name: Peripheral T-cell Lymphoma Prognostic Index Score 2


name: Peripheral T-cell Lymphoma Prognostic Index Score 3-4


name: International Prognostic Index Risk Group


name: International Prognostic Index Low-Intermediate Risk Group


name: International Prognostic Index High-Intermediate Risk Group


name: 14-N/15-N Metabolic Labeling Quantification


name: Selected Reaction Monitoring Quantification


name: Label-free Protein Quantification by LC/MS


name: Label-Free Peptide Level Quantification by LC/MS


name: Label-Free Protein Group Level Quantification by LC/MS


name: Label-Free Raw Feature Quantification by LC/MS


name: Label-Free Gene Level Quantification by LC/MS


name: Testosterone Less than or Equal to 50 ng/dL


name: Ki-67 Positive Cells Less than 10 Percent


name: Ki-67 Positive Cells Greater than 20 Percent


name: Allogeneic Bone Marrow Transplantation Recipient


name: Autologous Bone Marrow Transplantation Recipient


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Group Identifier


name: Ophthalmic Examinations Group Identifier


name: Urinary System Findings Group Identifier


name: Cardiovascular System Findings Link Identifier


name: Microbiology Susceptibility Link Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Link Identifier


name: Reproductive System Findings Link Identifier


name: Microbiology Specimen Link Group Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Link Group Identifier


name: Reproductive System Findings Link Group Identifier


name: Tumor Identification Link Group Identifier


name: Urinary System Findings Link Group Identifier


name: Cardiovascular System Findings Link Group


name: Solid Dispersion Immediate Release Tablet Dosage Form


name: Cardiovascular System Findings Reference Identifier


name: Functional Tests Sponsor-Defined Identifier


name: Functional Test Result or Finding in Original Units


name: Microbiology Specimen Focus of Study-Specific Interest


name: Microbiology Specimen Measurement, Test or Examination Detail


name: Microbiology Susceptibility Non-host Organism Identifier


name: Microbiology Susceptibility Measurement, Test or Examination Detail


name: Microbiology Susceptibility Modified Reported Name


name: Microbiology Susceptibility External File Path


name: Microbiology Susceptibility Analysis Method


name: Microbiology Susceptibility Collected Duration


name: Monoclonal Hematopoietic Stem and Progenitor Cells Present


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Sponsor-Defined Identifier


name: Nervous System Sponsor-Defined Identifier


name: Urinary System Findings Sponsor-Defined Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Elapsed Time


name: Reproductive System Findings Elapsed Time


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Reference Identifier


name: Respiratory System Findings Reference Identifier


name: Urinary System Findings Reference Identifier


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Time Point Reference


name: Ophthalmic Examinations Time Point Reference


name: Reproductive System Findings Time Point Reference


name: Respiratory System Findings Reference Result in Original Units


name: Proton Multiple Quantum Coherence Magnetic Resonance Spectroscopic Imaging


name: Ophthalmic Examinations External File Path


name: Urinary System Findings Time Point Reference


name: Disease Response or Clinical Classification Previous Occurrence


name: Healthcare Encounter Previous Occurrence


name: Microbiology Susceptibility Previous Occurrence


name: Disease Response or Clinical Classification Ongoing


name: Musculoskeletal Findings, Connective and Soft Tissue Findings Completion Status


name: Nervous System Findings Completion Status


name: Ophthalmic Examinations Completion Status


name: Ophthalmic Examinations Normal or Reference Range Indicator


name: Microbiology Susceptibility Normal or Reference Range Indicator


name: Microbiology Susceptibility Specimen Type


name: Microbiology Susceptibility Agent Concentration Unit


name: Spectral Domain-Optical Coherence Tomography


name: Blasts 1 Percent or More of Bone Marrow Nucleated Cells


name: Recombinant Human Plasminogen Kringle 5 Domain ABT 828


name: Was In Situ Hybridization Performed Question


name: Protein Expression Analysis by Immunohistochemistry


name: Additional Surgery for new Loco-Regional Tumor Event Not Evaluated


name: Bone Marrow Differential Count within 24 Hours of Banking


name: Additional Surgery for New Tumor Event Not Evaluated


name: Tumor Infiltrating Lymphocyte is Present


name: Navigated Transcranial Magnetic Stimulation


name: Whole Abdominopelvic Intensity-Modulated Radiotherapy


name: Behavioral Activation Intervention to Smoking Cessation and to Post-Cessation Weight Gain


name: Principal Statistical Analysis Plan Version


name: Statistical Analysis Plan Document Version


name: Specify Other Preoperative IV Antacids Administered Question


name: Specify Other Preoperative IV Antiemetics Administered Question


name: Revised International Prognostic Scoring System


name: Specify Other Spinal/Epidural Anesthesia Agents Administered Question


name: Montreal Cognitive Assessment Visuospatial/Executive Test


name: Montreal Cognitive Assessment Attention - Digits Test


name: Montreal Cognitive Assessment Attention - Letters Test


name: Montreal Cognitive Assessment Attention - Subtraction Test


name: Montreal Cognitive Assessment Language - Repeat Test


name: Montreal Cognitive Assessment Language - Fluency Test


name: Montreal Cognitive Assessment Delayed Recall Test


name: Baker Classification of Capsular Contracture of Breast


name: Beclomethasone Dipropionate/Formoterol Fumarate Inhalation Solution


name: Submicron Particle Paclitaxel Sterile Suspension


name: BardPort Titanium Implanted Port with Peritoneal Catheter


name: Immune Effector Encephalopathy - ICE Assessment


name: INC Demographic and Maternal Terminology


name: Date of Neonatal Intensive Care Unit Admission


name: Classical Leptomeningeal Disease Finding


name: Blasts 60 Percent or More of Peripheral Blood White Cells


name: Blasts 60 Percent or More of Bone Marrow Nucleated Cells


name: Mobility Independent But May Use Any Aid, Greater Than 50 Yards


name: Mortality Cut-off Year, National Death Index


name: Stay Focused and Think Clearly Under Pressure Question


name: Have Pins and Needles in Your Arm Question


name: PSA Level Greater than or Equal to Fifty


name: CDISC SEND Expected Onset of Rad/Nuc Targeted Injury Response Terminology


name: Fructosamine Corrected for Total Protein Measurement


name: Planned Challenge Agent Exposure Frequency


name: EORTC QLQ-C15-PAL Version 1 - Have You Felt Weak


name: EORTC QLQ-C30 Version 3 - Condition Caused Financial Difficulties


name: T1-DDS - Be Safe From Hypoglycemic Event


name: pH 10 Basic Reversed-Phase Liquid Chromatography


name: Nervous System Findings Group Identifier


name: Bifidobacterium longum/Lactobacillus acidophilus/Enterococcus faecalis Probiotic Supplement


name: Specify Number of Lymph Nodes Examined Question


name: Were Subsequent Known Primary Melanoma(s) Found During the Follow-Up Question


name: BRAF Rearrangement Analysis Was Performed


name: FNCLCC Sarcoma Grade GX Grade cannot be assessed


name: Cytogenetic Risk Group-CALGB Criteria for AML


name: ANHYDROUS CITRIC ACID 166 mg in 270 mL INTRAVENOUS INJECTION, SOLUTION [Citric Buffered Normal Saline]


name: CellPad Medical Grade Silicone Gel Matrix (Large)


name: Ensure Plant-Based Protein Nutrition Shake (Chocolate)


name: Ensure Plant-Based Protein Nutrition Shake (Vanilla)


name: Emergen-C Electrolyte Replenisher Powder for Solution (Lemon-Lime)


name: LEVOMEFOLATE CALCIUM 15 mg ORAL CAPSULE [Denovo]


name: menaquinone 500 mcg-100 mcg oral capsule


name: One Touch Ultra2 Syst 024-046 blood glucose m


name: Onetouch Delica Plus Lancing Device 023-973


name: PediaSure Peptide 1.0 Cal Liquid Strawberry


name: PediaSure Peptide 1.0 Cal Liquid Unflavored


name: Similac Advance Lamehadrin Infant Formula


name: Similac Go & Grow HMO Toddler Drink Powder Un


name: PediaSure Peptide 1.0 Cal Liquid Vanilla


name: PediaSure Peptide 1.5 Cal Liquid Vanilla


name: PediaSure with Fiber 1.0 Cal Liquid Vanilla


name: PediaSure with Fiber 1.5 Cal Liquid Vanilla


name: Contact Lens Product Ophthalmic Solution [Saline Solution]


name: Ointment, Multi Ingredient Topical application Ointment [Aveeno Repairing Cica Hand Mask]


name: Ointment, Multi Ingredient Topical application Ointment [Aveeno Repairing Cica Foot Mask]


name: Pyridoxal Phosphate 100 MG/1 GM Oral Powder [VB6 P5P]


name: Gel, Multi Ingredient Topical application Gel/Jelly [Copaderm]


name: Cleanser Topical application Soap [Aveeno Positively Radiant Brightening Daily Scrub]


name: Pyridoxal Phosphate 100 MG/1 GM Oral Powder


name: TITANIUM DIOXIDE 22 mg in 1 mL / ZINC OXIDE 11 mg in 1 mL TOPICAL LOTION [Svens Everyday Mineral Sunscreen]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 100 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 100 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 50]


name: AVOBENZONE 30 mg in 1 g / HOMOSALATE 80 mg in 1 g / OCTISALATE 50 mg in 1 g / OCTOCRYLENE 80 mg in 1 g TOPICAL SPRAY [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 30]


name: ALUMINUM SESQUICHLOROHYDRATE 17.6 g in 100 g TOPICAL AEROSOL, SPRAY [Degree]


name: LEVAMISOLE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: TOLAZOLINE HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: CEFPODOXIME PROXETIL 1 g in 1 g NOT APPLICABLE POWDER


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Candy 1]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 159 mg in 1 g TOPICAL STICK [Lady Speed Stick Invisible Dry Power Spring Blossom - antiperspirant/deodorant]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Dolce Vita]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OXYBENZONE 40 mg in 1 g TOPICAL STICK [Softlips Oasis Pineapple Coconut, Peach Mango, Strawberry Kiwi]


name: TEMOZOLOMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: BUTYLSCOPOLAMINE BROMIDE 1 g in 1 g NOT APPLICABLE POWDER


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Teen Be Positive]


name: Avobenzone 30 mg in 1 mL / Homosalate 100 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 50 mg in 1 mL / Oxybenzone 60 mg in 1 mL TOPICAL LOTION [La Roche Posay Laboratoire Dermatologique Anthelios 50 Daily Antiaging Primer with Sunscreen]


name: FAK Care4 Bus and School Yellow ORM D KIT


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Soft Creme]


name: Avobenzone/Octisalate/Octocrylene 3%-5%-10% Topical application Cream [Gold Bond Ultimate Neck & Chest Age Defense]


name: ZINC OXIDE 83.4 mg in 1 g / TITANIUM DIOXIDE 10 mg in 1 g TOPICAL GEL [Blue Lizard Sensitive Face Sunscreen]


name: HYDROXYETHYL CELLULOSE (140 CPS AT 5%) 3.84 g in 240 mL TOPICAL OIL [WeDol Water-based personal lubricant]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Sport Energy Women]


name: Niacinamide 0.60 g in 30 g / Adenosine 0.01 g in 30 g TOPICAL PATCH [Hyalu Plus Up Mask]


name: Niacinamide 0.60 g in 30 mL / Adenosine 0.01 g in 30 mL TOPICAL LIQUID [VIRGIN GRACE Hyalu Plus Serum]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Elements Canyon]


name: ZINC OXIDE 2.8 mg in 30 mL / TITANIUM DIOXIDE 4.3 mg in 30 mL TOPICAL LIQUID [Revlon Youth FX]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Country]


name: ALUMINUM SESQUICHLOROHYDRATE 24 g in 100 g TOPICAL AEROSOL, SPRAY [Antiperspirant Above Fresh]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [TimeWise Repair VoluFirm Day Cream SPF 30 Broad Spectrum Sunscreen]


name: ZINC OXIDE 210 mg in 1 g TOPICAL CREAM [Prevention Plus Daily Tinted Moisturizer SPF 30]


name: Dimethicone;Triamcinolone Acetonide 5%; 0.1% Topical application Cream [Trivix]


name: ASCORBIC ACID 125 mg / CHOLECALCIFEROL 0.0125 mg / THIAMINE 1.4 mg / PYRIDOXAL PHOSPHATE ANHYDROUS 2.5 mg / FOLIC ACID 1 mg / METHYLCOBALAMIN 1 mg / CALCIUM CARBONATE 200 mg / FERROUS GLUCONATE 13 mg / POTASSIUM IODIDE 0.15 mg ORAL TABLET [Zalvit]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4.5 g in 100 g TOPICAL CREAM [TimeWise Repair Volu-Firm Day Cream SPF 30 Broad Spectrum Sunscreen]


name: colostomy bag, non-sterile 1 9/16"-2" (12") MISCELL EACH


name: silver/silicone/foam bandage 4" X 4" TOPICAL BANDAGE


name: clindamycin/benzoyl/octinox/octyl/octocryl/oxyben/titanium 1 %-2.5 %-SPF 50 TOPICAL KIT, GEL AND LOTION


name: clindamycin/octinoxate/octyl salicyl/octocryl/oxybenz/titan 1 %-SPF 50 TOPICAL KIT, GEL AND LOTION


name: diclofenac sodium/menthol/camphor 75 mg-3 %-3 % MISCELL KIT, GEL AND TABLET DELAYED RELEASE


name: kit for the preparation of Tc-99m/sodium oxidronate 3.15 mg INTRAVEN VIAL (EA)


name: cardioplegic solution no.26 (maintenance 4:1)


name: cardioplegic solution no.27 (induction 4:1)


name: cardioplegic solution no.28 (reperfusate 4:1)


name: cardioplegic solution no.29 (maintenance 4:1)


name: cardioplegic solution no.30 (induction 4:1)


name: influenza A virus A/Kansas/14/2017 (H3N2) antigen / influenza A virus A/Switzerland/3330/2017 (H1N1) antigen / influenza B virus B/Colorado/06/2017 antigen / influenza B virus B/Phuket/3073/2013 antigen


name: camphor / menthol / methyl salicylate / methylsulfonylmethane


name: DRESSING,OPTIFOAM SITE 4IN X 4IN #MSC1104


name: CATHETER,INTERMITTENT 12FR FEMALE CURE #CQT12


name: CATHERIZATION SET,FOLEY 14FR BARD #772417


name: CATHETER,INTERMITTENT 12FR LOFRIC HYDRO-KIT COUDE #4251240


name: MASK,AEROSOL ADULT FACE TENT MEDLINE #HCS4630


name: TRACH ANTI-DISCONNECT DEVICE,SHILEY #SSDD


name: TUBING,SUCTION 1/4IN X 6FT COVIDIEN #8888301606


name: CATHETER FOLEY 3-WAY 18FR 5ML BARD #70518L


name: DRESSING,OPTIFOAM GENTLE POST-OP 4IN X 8IN #MSC2148


name: CATHETER,INTERMITTENT,GENTLECATH 16FR FEMALE #421574


name: SUCTION TUBE ATTACHMENT DEVICE CARDINAL #501015


name: ADAPTER,NEBULIZER VALVED CAREFUSION #2061


name: LEG BAG STRAP,SPORT,MEDIUM,UROCARE #6343


name: Myocardial late gadolinium enhancement MRI


name: False positive radioisotope investigation result


name: Positron emission tomogram breast abnormal


name: Scheduled weekly dosing taken more frequently


name: Scheduled weekly dosing taken less frequently


name: Scheduled daily dosing taken less frequently


name: Scheduled daily dosing taken more frequently


name: Scheduled monthly dosing taken less frequently


name: Urinary neutrophil gelatinase-associated lipocalin


name: Neutrophil gelatinase-associated lipocalin increased


name: Increased urinary neutrophil gelatinase-associated lipocalin


name: Occupational exposure via skin contact with product


name: Product dosage form identification issue


name: Device ineffective for unapproved indication


name: Macrophage inflammatory protein-1 alpha decreased


name: Monocyte chemotactic protein-2 decreased


name: Macrophage inflammatory protein-1 alpha increased


name: Magnetic resonance imaging breast normal


name: Magnetic resonance imaging spinal normal


name: Magnetic resonance imaging spinal abnormal


name: Magnetic resonance imaging thoracic abnormal


name: Product used prior to being brought to recommended temperature


name: Duplicate therapy with same active substance


name: Delivery device component difficult to use


name: Hepatic venous pressure gradient increased


name: Hepatic venous pressure gradient abnormal


name: Scheduled monthly dosing taken more frequently


name: Percutaneous transhepatic biliary drainage catheter insertion


name: Monocyte chemotactic protein-2 increased


name: Dental Providers; Dentist, Orofacial Pain


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Gerontological"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Obesity and Weight Management"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Oncology"


name: Dietary & Nutritional Service Providers; "Dietitian, Registered", "Nutrition, Sports Dietetics"


name: Radiation Oncology Quality Assurance Information System Software


name: Monitors, Cardiac Ventricular Assist System


name: Implantable Sensor Left Atrial Pressure Monitoring Systems


name: Vented Noninvasive Ventilation Interfaces


name: Non-Vented Noninvasive Ventilation Interfaces


name: Sterilization Process Challenge, Packs, Biological/Chemical


name: Hemostatic Agents, Surgical, Non-Absorbable


name: Orthopedic Fixation Systems, Implantable, Spine, Interbody Fusion


name: Orthopedic Fixation Systems, Implantable, Spine, Thoracolumbar, Interbody Fusion, Synthetic


name: Interbody Fusion Devices, Thoracic Spine


name: Cardiopulmonary Resuscitation Automated Assistance Devices


name: Sterilization Process Challenge Packs, Biological


name: Sterilization Process Challenge Packs, Chemical


name: Programmer/Testers, Implantable Cardiac Circulatory Assist Unit


name: Cardiopulmonary Resuscitation Compression Feedback Devices


name: Nucleic Acid Processors, Replication, Thermal Cycle, Digital Polymerase Chain Reaction


name: Interbody Spinal Fusion Implants, Thoracolumbar


name: Software, Information Systems, Healthcare Facility, Clinical, Radiotherapy, Quality Assurance


name: Monitoring Systems, Physiologic, Left Atrial Pressure, Telemetric, Implantable Sensor


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Oronasal


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Nasal


name: Analyzers, Physiologic, Cardiovascular Function, Flow-Mediated Skin Fluorescence


name: Simulators, Training, Extracorporeal Membrane Oxygenation


name: IVD Panels, Human Genetics, Encephalopathy, Brain Malformation, Septo-Optic Dysplasia


name: IVD Panels, Human Genetics, Neuromuscular Disorder, Periodic Paralysis


name: IVD Panels, Human Genetics, Vascular Malformation, Cerebral Cavernous


name: IVD Panels, Human Genetics, Mitochondrial Disorder, Primary Coenzyme Q10 Deficiency


name: IVD Panels, Human Genetics, Blood Disorder, Thrombotic Microangiopathy


name: IVD Panels, Human Genetics, Connective Tissue Disorder, Cutis Laxa


name: IVD Panels, Human Genetics, Encephalopathy, Brain Malformation, Holoprosencephaly


name: IVD Panels, Human Genetics, Neuromuscular Disorder, Collagen VI-Related Myopathy


name: IVD Panels, Human Genetics, Metal Accumulation, Copper/Iron, Mutation


name: Intravenous Poles, Free-Standing, Lift-Assistance


name: IVD Panels, Human Genetics, Pancreatic Disorder, Pancreatitis


name: Surgical Drapes, Patient, Disposable, Abdominal Procedure


name: Masks, Air-Oxygen, Positive Airway Pressure Unit


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Oral


name: Masks, Air-Oxygen, Positive Airway Pressure Unit, Total Face


name: Masks, Air-Oxygen, Non-Invasive Positive Pressure Ventilator


name: Procedure Kit/Trays, Irrigation/Lavage, Ostomy


name: Software, Information System, Healthcare Facility, Administrative, Internet of Things Security


name: IVD Panels, Human Genetics, Metabolic Disorder, Metal Accumulation, Comprehensive, Mutation


name: IVD Panels, Human Genetics, Pancreatitis


name: IVD Test Reagent/Kits, Multimodal Assay, Chromosome Anomaly/Gene Anomaly


name: IVD Test Reagent/Kits, Molecular Assay, Gene Anomaly, Mutation, PIK3CA


name: IVD Test Reagent/Kits, Mass Spectrometry, Preeclampsia


name: Hemostatic Agents, Surgical, Oxidized Regenerated Cellulose


name: Hemostatic Agents, Surgical, Polysaccharide Spheres


name: Hemostatic Agents, Surgical, Thrombin-Containing


name: Interbody Spinal Fusion Implants, Cervical


name: Paragangliomas 3 (PGL3) Gene Anomaly Detection


name: Medicare Chronic Condition Special Needs Plan (C-SNP)


name: Medicare Institutional Special Needs Plan (I-SNP)


name: Dual Eligible Special Needs Plan (D-SNP)


name: Fully Integrated Dual Eligible Special Needs Plan (FIDE-SNP)


name: Abnormality of circulating adrenocorticotropic hormone level


name: Conception by assisted reproductive technology


name: Blood pressure substantially higher in legs than arms


name: Blood pressure substantially higher in arms than legs


name: Increased circulating adrenic acid concentration


name: Reduced response to gonadotropin-releasing hormone stimulation test


name: Reduced circulating cholinesterase activity


name: Abnormal proportion of CD8-positive TEMRA T cells


name: Abnormal circulating haptoglobin concentration


name: Abnormal circulating A-type atrial natriuretic peptide concentration


name: Increased circulating A-type natriuretic peptide concentration


name: Decreased circulating A-type natriuretic peptide concentration


name: Increased circulating arachidonic acid concentration


name: Abnormal circulating 18-hydroxycorticosterone level


name: Decreased circulating 18-hydroxycortisone level


name: Increased circulating 18-hydroxycortisone level


name: Persistent asymmetrical tonic neck reflex


name: Decreased expression of GPI-anchored proteins on the cell surface


name: Increased hepatitis A virus antibody level


name: Increased hepatitis B virus antibody level


name: Increased hepatitis C virus antibody level


name: Diclofenac Sodium;Menthol 1.5%; 10% Topical application Solution [DiMentho]


name: ReliOn Premier Classic Blood Glucose Monitoring System


name: Gel, Multi Ingredient Topical application Pad [Scarcin Pad]


name: Medical Food Oral Powder for Suspension [PKU explore5]


name: Medical Food Oral Powder for Suspension [PKU explore10]


name: Electrolytes Oral Solution [Oralyte Pediatric Electrolyte]


name: Cleanser Topical application Pad [Leader Baby Wipes]


name: Ascorbic Acid/Calcium/Cholecalciferol/Ferrous Gluconate/Folic Acid/Methylcobalamin/Potassium Iodide/Pyridoxal Phosphate/Thiamine Hydrochloride 125 MG-200 MG-12.5 MCG-13 MG-1 MG-1000 MCG-150 MCG-2.5 MG-1.4 MG Oral Tablet


name: 5-Methyltetrahydrofolate Calcium/alpha Tocopherol/Ascorbic Acid/Beta Carotene/Biotin/Calcium Carbonate/Cholecalciferol/Cyanocobalamin/Ferrous Bisglycinate Chelate/Folic Acid/Magnesium Oxide/Potassium Iodide/Pyridoxine Hydrochloride 1 MG-4.5 MG-60 MG-300 MCG-0.28 MG-80 MG-10 MCG-0.013 MG-20 MG-0.67 MG-25 MG-0.15 MG-26 MG Oral Tablet


name: SECNIDAZOLE 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 1000 mg in 1 mL / OCTISALATE 202.5 mg in 1 mL / OCTOCRYLENE 640 mg in 1 mL TOPICAL LOTION [Sunscreen]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / AVOBENZONE 30 mg in 1 g TOPICAL CREAM [Exuviance Daily Corrector with Sunsreen Broad Spectrum SPF 35]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Aveeno Kids Continuous Protection Sensitive Skin Mineral Sunscreen Broad Spectrum SPF 50]


name: ZINC OXIDE 216 mg in 1 g TOPICAL STICK [Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Axe]


name: Ketoconazole;Miconazole Nitrate 2%; 2% Topical application Kit [PedizolPAK]


name: LIDOCAINE HYDROCHLORIDE 10 mg in 1 mL TOPICAL LIQUID [NATURES CRAFT LIDOCAINE Male Genital Desensitizer]


name: OCTISALATE 5 g in 100 g / OXYBENZONE 3 g in 100 g / OCTINOXATE 7 g in 100 g TOPICAL SPRAY [HAMPTON SUN]


name: OCTINOXATE 4 g in 100 g / OXYBENZONE 2 g in 100 g TOPICAL GEL [HAMPTON SUN]


name: AVOBENZONE 25 mg in 1 mL / HOMOSALATE 60 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF30]


name: AVOBENZONE 25 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 80 mg in 1 mL TOPICAL LOTION [Neutrogena Clear Body Breakout Free Oil Free Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF45]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Ultra Sheer Dry Touch Sunscreen Broad Spectrum SPF55]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 45 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF 70]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 150 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Neutrogena Beach Defense Water Plus Sun Protection Sunscreen Broad Spectrum SPF50]


name: OCTISALATE 20 mg in 1 mL / OCTINOXATE 75 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL LOTION [Up and Up Illuminating Daily Moisturizer with Sunscreen Broad Spectrum SPF 15]


name: DIMETHICONE 20 mg in 1 g / OCTINOXATE 75 mg in 1 g / OCTISALATE 30 mg in 1 g / OXYBENZONE 30 mg in 1 g TOPICAL STICK [Softlips Vanilla Watermelon]


name: TITANIUM DIOXIDE 0.032 g in 1 mL / ZINC OXIDE 0.077 g in 1 mL TOPICAL CREAM [RECHARGE Protect Blur]


name: ZINC OXIDE 216 mg in 1 mL TOPICAL LOTION [Neutrogena Sheer Zinc Kids Mineral Sunscreen Broad Spectrum SPF 50 Plus]


name: HOMOSALATE 7 g in 100 g / OCTOCRYLENE 5 g in 100 g / AVOBENZONE 2 g in 100 g TOPICAL SPRAY [BANANA BOAT]


name: ISOPROTERENOL HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: TRAMETINIB 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 1.285 g in 50 mL / OCTINOXATE 3.8036 g in 50 mL / OCTOCRYLENE 1.542 g in 50 mL TOPICAL EMULSION [SHISEIDO WHITE LUCENT DAY]


name: Diclofenac Sodium 3% Topical application Gel/Jelly [Solaravix]


name: TELMISARTAN 1 g in 1 g NOT APPLICABLE POWDER


name: CHLORAMPHENICOL PALMITATE 1 kg in 1 kg NOT APPLICABLE POWDER


name: CLEMASTINE FUMARATE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTINOXATE 60 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OXYBENZONE 35 mg in 1 mL TOPICAL CREAM [BB SPF20]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 13]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 21]


name: ZINC OXIDE 0.07 g in 1 g / TITANIUM DIOXIDE 0.0419 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB No 31]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL LOTION [Leader General Protection SPF 30 Sunscreen]


name: TITANIUM DIOXIDE 0.042 g in 1 g / ZINC OXIDE 0.07 g in 1 g / OCTINOXATE 0.075 g in 1 g TOPICAL CREAM [MISSHA M Perfect Cover BB SPF42 No23]


name: AVOBENZONE 20 mg in 1 g / HOMOSALATE 40 mg in 1 g / OCTISALATE 40 mg in 1 g / OCTOCRYLENE 20 mg in 1 g TOPICAL GEL [Neutrogena Hydro Boost City Shield water Broad Spectrum SPF 25]


name: {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack [Trikafta (100 MG / 50 MG / 75 MG; 150 MG)]


name: {30 (24 HR amantadine 129 MG Extended Release Oral Tablet [Osmolex]) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet [Osmolex]) } Pack [Osmolex 322 MG Daily Dosing]


name: selenium sulfide micronized 52 % to 55.5 % MISCELL POWDER (GRAM)


name: diluent for lefamulin(10mM citrate buffered 0.9 % sod chlor) INTRAVEN PLASTIC BAG, INJECTION (ML)


name: folic acid and methyltetrahydrofolate calcium


name: parenteral electrolytes combination no.31


name: parenteral electrolytes combination no.32


name: parenteral electrolytes combination no.33


name: diluent for dengue vacc, vero cell 0.4 % sod chlor


name: diluent for lefamulin (10mM citrate 0.9 % sod chl)


name: {56 (elexacaftor 100 MG / ivacaftor 75 MG / tezacaftor 50 MG Oral Tablet) / 28 (ivacaftor 150 MG Oral Tablet) } Pack


name: {30 (24 HR amantadine 129 MG Extended Release Oral Tablet) / 30 (24 HR amantadine 193 MG Extended Release Oral Tablet) } Pack


name: hard maple pollen extract / red maple pollen extract


name: California black walnut pollen extract / English walnut pollen extract


name: oneseed juniper pollen extract / Rocky Mountain juniper pollen extract


name: CATHETER,INTERMITTENT COUDE 14FR COLOPLAST #20024


name: CATHETER,SUCTION 10FR MAXIFLO SMITHS #640010


name: CLEANSING CLOTH,ALOETOUCH PKT M#MSC095228


name: BANDAGE TUBULAR ELASTIC 4IN X 11YD SAG13115


name: DRESSING,ALLEVYN GENTLE BORDER LITE 7.5CM X 7.5CM #66020412


name: DRESSING,COLACTIVE PLUS AG 4IN X 4IN #10340000


name: DRESSING,CUTIMED SORBION SORBACT 4IN X 4IN #7269808


name: DRESSING,CUTIMED SORBION SORBACT 8IN X 12IN #7269811


name: DRESSING,HYDROFERA BLUE HEAVY DRAINAGE 6IN X 6IN HBHD6675


name: DRESSING,OPTIFOAM NON-ADHESIVE 3IN X 3IN #MSC1133F


name: DRESSING,POLYMEM MAX 3.5IN X 3.5IN,FERRIS #606


name: KIT PREP OF TECHNETUM TC-99 OXIDRONATE SODIUM INJ


name: KIT PREP OF TECHNETUM TC-99 TILMANOCEPT INJ


name: SALIVA,ARTIFICIAL (GC DRY MOUTH) GEL,DENT


name: Leader Pediatric Electrolyte Solution (Bubblegum)


name: Leader Pediatric Electrolyte Solution (Grape)


name: Leader Pediatric Electrolyte Solution (Strawberry)


name: OMRON MICRO Air Vibrating Mesh Nebulizer


name: Pedialyte Sparkling RUSH Electrolyte Powder for Solution (Cherry)


name: Pedialyte Sparkling RUSH Electrolyte Powder for Solution (Grape)


name: ReliOn Premier BLU Blood Glucose Monitoring System


name: ReliOn Premier Compact Blood Glucose Monitoring System


name: ReliOn Premier Voice Blood Glucose Monitoring System


name: Glytactin RTD LITE 15PE Suspension (Coffee Mocha)


name: Glytactin RTD LITE 15PE Suspension (Vanilla)


name: Cellpad Medical Grade Silicone Gel Matrix


name: Discount Drug Mart Pentips Plus Pen Needles,


name: Blink RevitaLens Multi-Purpose Disinfecting S


name: Cream, Multi Ingredient Topical application Cream [Leader Minerin Creme]


name: AMINOCAPROIC ACID 1 g in 1 g NOT APPLICABLE POWDER


name: Avobenzone 30 mg in 1 g / Octisalate 50 mg in 1 g / Octocrylene 70 mg in 1 g TOPICAL CREAM [Lancome Paris Renergie Lift MultiAction Ultra Lifting Firming Dark Spot Correcting Broad Spectrum SPF 30 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL / TITANIUM DIOXIDE 32 mg in 1 mL TOPICAL LIQUID [Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 27 Sunscreen]


name: OCTINOXATE 75 mg in 1 mL TOPICAL LIQUID [Lancome Paris Renergie Lift Makeup Broad Spectrum SPF 26 Sunscreen]


name: OCTINOXATE 75 mg in 1 g / OXYBENZONE 50 mg in 1 g TOPICAL LIPSTICK [Neutrogena Revitalizing Lip Balm SPF 20 - Fresh Plum 60]


name: ZINC OXIDE 240 mg in 1 mL TOPICAL LOTION [MUSTELA MINERAL SUNSCREEN BROAD SPECTRUM SPF 50]


name: BASIC FIBROBLAST GROWTH FACTOR (HUMAN) 0.001 g in 100 mL TOPICAL LIQUID [Oliglo Multi-Action Peptide Gel Pack]


name: GREEN TEA LEAF 1.2 g in 100 mL TOPICAL LIQUID [Oliglo Lifting Serum]


name: AVOBENZONE 27 mg in 1 mL / HOMOSALATE 40 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL / OXYBENZONE 45 mg in 1 mL TOPICAL LOTION [Neutrogena Clear Face Breakout Free Oil Free Broad Spectrum SPF 55]


name: Titanium Dioxide 85.4 mg in 1 mL / Zinc Oxide 40.7 mg in 1 mL TOPICAL CREAM [TiZO2]


name: AVOBENZONE 90 mg in 1 g / HOMOSALATE 225 mg in 1 g / OCTISALATE 250 mg in 1 g / OCTOCRYLENE 1000 mg in 1 g TOPICAL SPRAY [Sunscreen]


name: TITANIUM DIOXIDE 10 mg in 1 mL / ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [ZO Skin Health Sunscreen Plus Primer Broad-Spectrum SPF 30]


name: CIPROFLOXACIN HYDROCHLORIDE 1 g in 1 g NOT APPLICABLE POWDER


name: Benzalkonium Chloride;Lidocaine/Prilocaine 0.13%; 2.5%-2.5% Topical application Kit [Microvix LP]


name: ZINC OXIDE 200 mg in 1 g TOPICAL CREAM [CoTZ Flawless Complexion]


name: ZINC OXIDE 200 mg in 1 g TOPICAL CREAM [TiZO Ultra Zinc SPF 40 (Tinted)]


name: OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL / OCTOCRYLENE 10 g in 100 mL TOPICAL LOTION [Hand Screen Broad Spectrum Sunscreen SPF 40]


name: DICLAZURIL 1 g in 1 g NOT APPLICABLE POWDER


name: IDOXURIDINE 1 g in 1 g NOT APPLICABLE POWDER


name: OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL / AVOBENZONE 30 mg in 1 mL TOPICAL CREAM [AMBI SKINCARE Even and Clear Daily Facial Moisturizer SPF 30]


name: OCTINOXATE 75 mg in 1 g / OCTISALATE 50 mg in 1 g / OXYBENZONE 30 mg in 1 g / TITANIUM DIOXIDE 67.4 mg in 1 g TOPICAL CREAM [COVER plus CORRECT/TINTED MOISTURIZER CC CRM FAIR]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 15 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 8 g in 100 g TOPICAL SPRAY [TRADER JOES SUNSCREEN SPF 50]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / OCTOCRYLENE 7 g in 100 mL TOPICAL LOTION [TRADER JOES FACE AND BODY SUNSCREEN SPF 30]


name: Zinc Oxide 200 mg in 1 g TOPICAL CREAM [CoTZ Baby]


name: GLYCERIN 2 g in 100 mL TOPICAL LOTION [Zenibell Snail Intensive]


name: LIDOCAINE 10 mg in 1 mL TOPICAL OINTMENT [Prolayed Lidocaine Male Genital Desensitizer]


name: OCTOCRYLENE 6.5 g in 100 g / AVOBENZONE 2.7 g in 100 g / HOMOSALATE 9 g in 100 g / OCTISALATE 4.5 g in 100 g TOPICAL LOTION [Banana Boat Ultra Sport Sunscreen Broad Spectrum SPF 50]


name: LOSARTAN POTASSIUM 1 g in 1 g NOT APPLICABLE POWDER


name: AVOBENZONE 90 mg in 1 mL / HOMOSALATE 2250 mg in 1 mL / OCTISALATE 250 mg in 1 mL / OCTOCRYLENE 1000 mg in 1 mL TOPICAL LOTION [SUNSCREEN]


name: GLYCERIN 2 g in 100 g TOPICAL CREAM [Zenibell Snail IntensiveCream]


name: GLYCERIN 2 g in 100 mL TOPICAL LIQUID [Zenibell Snail Intensive Toner]


name: PETROLATUM 86 mg in 1 g TOPICAL OINTMENT [Resurfix Plus]


name: infant form.iron, lact.reduced/dha/arachidonic acid (ara) 2.2 gram-5.3 gram-10.9 gram/100 kcal ORAL POWDER (GRAM)


name: syringe with needle,insulin,0.5 mL 32 gauge X 5/16" MISCELL SYRINGE, EMPTY DISPOSABLE


name: nutritional therapy, glucose intolerance,soy 10 gram-160 kcal/40 gram ORAL BAR


name: AEROSOL POWDER, BREATH ACTIV WITH SENSOR


name: allantoin / benzocaine / camphor / dimethicone / menthol / petrolatum


name: PROSOURCE GELATEIN PLUS PINEAPPLE GEL,ORAL


name: CATHETER,INTERMITTENT 18FR LOFRIC HYDRO-KIT #4201840


name: CATHETER,INTERMITTENT COUDE 12FR LOFRIC PRIMO #4151240


name: CATHETER,INTERMITTENT,GENTLECATH 16FR FEMALE #501023


name: FEEDING BAG W/PUMP SET ENFIT COVIDIEN #772055


name: PRONTOSAN WOUND IRRIGATION BRAUN #400441


name: Medical Dictionary for Regulatory Activities Terminology (MedDRA), Korean Edition


name: Regurgitant blood flow pressure half-time


name: Gene product metabolic activity interpretation


name: IRF-PAI v3.0, LCDS v4.00, OASIS E - Health conditions - discharge or expired or transfer


name: LCDS v4.00 - Signs and Symptoms of Delirium (from CAM)


name: LCDS v4.00 - Self-care - discharge performance


name: LCDS v3.00 - Bladder and bowel - planned discharge


name: LCDS v4.00 - Self-care - admission performance


name: LCDS v4.00 - Skin conditions - discharge


name: LCDS v4.00 - Spontaneous breathing trial


name: MDS v3.0 - RAI v1.17.2 - Optional state assessment


name: Outcome and assessment information set (OASIS) form - version D1:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1


name: OASIS D1 - Patient history and diagnoses - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS D1 - Patient history and diagnoses - follow-up


name: OASIS D1 - ADL and IADLs - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches:Find:Pt:^Patient:Ord:NuMoM2b


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken


name: Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby


name: Other things you are feeling bothered, upset or worried about:Find:Pt:^Patient:Nom:NuPDQ


name: Other things you are feeling bothered, upset or worried about


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches


name: Physical symptom of pregnancy that you are feeling bothered, upset or worried about:Find:Pt:^Patient:Nom:NuPDQ


name: Physical symptom of pregnancy that you are feeling bothered, upset or worried about


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby


name: Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby:Find:Pt:^Patient:Nom:NuPDQ


name: Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes:Find:Pt:^Patient:Ord:NuPDQ


name: Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes


name: Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version:-:Pt:^Patient:-:NuPDQ


name: Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version


name: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form:-:Pt:^Patient:-:NuMoM2b


name: Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form


name: Quality of Working Life Questionnaire for Cancer Survivors:-:4W:^Patient:-:QWLQ-CS


name: Quality of Working Life Questionnaire for Cancer Survivors


name: During the past 4W, working gives me structure in my life:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, working gives me structure in my life


name: During the past 4W, I think it is good to work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I think it is good to work


name: During the past 4W, I consider that my work gives me a goal in life:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider that my work gives me a goal in life


name: During the past 4W, I consider my work important:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider my work important


name: During the past 4W, I do my work well:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am self-confident in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am self-confident in my work


name: During the past 4W, I am suited to my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am suited to my work


name: During the past 4W, I have control over the work I do:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have control over the work I do


name: During the past 4W, I feel powerless in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel powerless in my work


name: During the past 4W, I feel there is a positive atmosphere in my working environment:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel there is a positive atmosphere in my working environment


name: During the past 4W, I have the feeling I am taken seriously by people in my working environment:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have the feeling I am taken seriously by people in my working environment


name: During the past 4W, I am content with my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with my work


name: During the past 4W, I have good relations with my colleagues:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have good relations with my colleagues


name: During the past 4W, I feel valuable to my colleagues:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I feel valuable to my colleagues


name: During the past 4W, my immediate superior understands my health situation and possible health problems:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, my immediate superior understands my health situation and possible health problems


name: During the past 4W, I have good relations with my immediate superior:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I have good relations with my immediate superior


name: During the past 4W, I consider that employees with health problems are treated well in my organization:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I consider that employees with health problems are treated well in my organization


name: During the past 4W, I am content with the fringe benefits provided by my employer:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with the fringe benefits provided by my employer


name: During the past 4W, I am content with my current income:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am content with my current income


name: During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy


name: During the past 4W, I am limited in my work:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, I am limited in my work


name: During the past 4W, because of my health situation I have little trust in my own body:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I have little trust in my own body


name: During the past 4W, because of my health situation I feel uncertain about the future:Find:4W:^Patient:Ord:QWLQ-CS


name: During the past 4W, because of my health situation I feel uncertain about the future


name: Perception of your work situation:-:4W:^Patient:-:QWLQ-CS


name: Atmosphere in your working environment:-:4W:^Patient:-:QWLQ-CS


name: Understanding and recognition in your organization:-:4W:^Patient:-:QWLQ-CS


name: Understanding and recognition in your organization


name: Problems due to your health situation:-:4W:^Patient:-:QWLQ-CS


name: Difficulties in Pregnancy total score:Score:Pt:^Patient:Qn:NuMoM2b


name: Dark-mediated rod adaptation time:Time:Pt:Eye.right:Qn


name: Dark-mediated rod adaptation time:Time:Pt:Eye.left:Qn


name: New York Heart Association Functional Classification:-:Pt:^Patient:-:NYHA


name: New York Heart Association Functional Classification


name: Sit to stand^with use of upper extremities:NRat:30S:^Patient:Qn


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0:-:RptPeriod:^Patient:-:CMS Assessment


name: Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0


name: Bone development stage:Score:Pt:Upper extremity>Radius:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.trapezoid:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.trapezium:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.scaphoid:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.lunate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.triquetrum:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.hamate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Wrist.capitate:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Thumb.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.distal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.middle phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.middle phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.fifth.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Finger.third.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Thumb.proximal phalanx:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.fifth:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.third:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Hand.metacarpal.first:Qn:XR


name: Bone development stage:Score:Pt:Upper extremity>Ulna:Qn:XR


name: Drug classes that have an indication documented:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Drug classes that have an indication documented


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - High risk drug classes - use and indication


name: How much of the time has pain made it hard for you to sleep at night:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy:Find:Pt:^Patient:Ord:OASIS


name: How Often Need Help Reading Instructions, Pamphlets, or other Written Material from Doctor or Pharmacy Question


name: How often have you limited your day-to-day activities because of pain:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you feel lonely or isolated from those around you:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: How often do you feel lonely or isolated from those around you


name: How often have you limited your participation in rehabilitation therapy sessions due to pain over:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: IRF-PAI v4.0 - Administrative information:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Administrative information


name: IRF-PAI v4.0 - Cognitive patterns - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Cognitive patterns - admission


name: IRF-PAI v4.0 - Cognitive patterns - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Cognitive patterns - discharge


name: IRF-PAI v4.0 - Health conditions - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Health conditions - admission


name: IRF-PAI v4.0 - Hearing, speech, and vision - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Hearing, speech, and vision - admission


name: IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, OASIS E - Hearing, speech, and vision - ROC, DC


name: IRF-PAI v4.0 - Identification information:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Identification information


name: IRF-PAI v4.0, LCDS v5.00 - Medications - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Medications - admission


name: IRF-PAI v4.0, LCDS v5.00 - Medications - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Medications - discharge


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00, OASIS E - Mood


name: IRF-PAI v4.0 - Quality indicators - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Quality indicators - admission


name: IRF-PAI v4.0 - Quality indicators - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Quality indicators - discharge


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - admission


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge


name: IRF-PAI v4.0 - Swallowing &or nutritional status - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Swallowing &or nutritional status - admission


name: IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge


name: IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired


name: IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Nutritional approaches - last 7D and discharge


name: Provision of current reconciled medication list to patient at discharge:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Provision of current reconciled medication list to patient at discharge


name: Provision of current reconciled medication list to subsequent provider at discharge:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Provision of current reconciled medication list to subsequent provider at discharge


name: Route of current reconciled medication list transmission to patient:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Route of current reconciled medication list transmission to patient


name: Route of current reconciled medication list transmission to subsequent provider:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Route of current reconciled medication list transmission to subsequent provider


name: Special treatments, procedures, and programs at discharge:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Special treatments, procedures, and programs at discharge


name: Preferred language & interpreter need:-:Pt:^Patient:-


name: IRF-PAI v4.0 - Administrative information - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: IRF-PAI v4.0 - Administrative information - discharge


name: Total skeletal maturity score:Score:Pt:Upper extremity>Wrist+Hand:Qn:XR


name: TPMT gene & NUDT15 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: TPMT gene & NUDT15 gene targeted mutation analysis


name: NUDT15 gene targeted mutation analysis:Prid:Pt:Bld/Tiss:Nom:Molgen


name: NUDT15 gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: NUDT15 gene product metabolic activity interpretation


name: Warfarin response genotype panel:-:Pt:Bld/Tiss:-:Molgen


name: Ehlers-Danlos syndrome multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Ehlers-Danlos syndrome multigene analysis


name: Coronary heart disease multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Coronary heart disease multigene analysis


name: Ventilator weaning status:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: LCDS v5.00 - Spontaneous breathing trial:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Spontaneous breathing trial


name: LCDS v5.00 - Special treatments, procedures, and programs - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Special treatments, procedures, and programs - discharge


name: LCDS v5.00 - Special treatments, procedures, and programs - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Special treatments, procedures, and programs - admission


name: LCDS v5.00 - Swallowing &or nutritional status - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Swallowing &or nutritional status - admission


name: LCDS v5.00 - Health conditions - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Health conditions - admission


name: LCDS v5.00 - Functional abilities and goals - planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Functional abilities and goals - planned discharge


name: LCDS v5.00 - Functional abilities and goals - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Functional abilities and goals - admission


name: LCDS v5.00 - Cognitive patterns - unplanned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Cognitive patterns - unplanned discharge


name: Deprecated LCDS v5.00 - Cognitive patterns - planned discharge [CMS Assessment]


name: LCDS v5.00 - Cognitive patterns - planned discharge


name: LCDS v5.00 - Cognitive patterns - admission and planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Cognitive patterns - admission and planned discharge


name: LCDS v5.00 - Hearing, speech, and vision - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Hearing, speech, and vision - discharge


name: LCDS v5.00 - Hearing, speech, and vision - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Hearing, speech, and vision - admission


name: LCDS v5.00 - Administrative information - expired:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Administrative information - expired


name: Administrative information:-:RptPeriod:^Patient:-:CMS Assessment (93217-8)


name: LCDS v5.00 - Administrative information - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Administrative information - admission


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00:-:RptPeriod:^Patient:-:CMS Assessment


name: Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00


name: LCDS v5.00 - Patient demographic information - unplanned discharge and expired:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Patient demographic information - unplanned discharge and expired


name: LCDS v5.00 - Patient demographic information - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Patient demographic information - admission


name: LCDS v5.00 - Patient demographic information - planned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Patient demographic information - planned discharge


name: LCDS v5.00 - Administrative information - unplanned discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v5.00 - Administrative information - unplanned discharge


name: Coagulation:Time:Pt:PPP:Qn:Coag.dilute Russell viper venom induced.post heparin neutralization


name: Coagulation:Time:Pt:PPP:Qn:Coag.surface induced.lupus sensitive.post heparin neutralization


name: Coagulation:Time:Pt:PPP:Qn:Coag.surface induced.lupus sensitive.excess phospholipid.post heparin neutralization


name: Coagulation actual/Normal:RelTime:Pt:PPP:Qn:Coag.surface induced.lupus sensitive.excess phospholipid.post heparin neutralization


name: Coagulation:Time:Pt:PPP:Qn:Coag.dilute Russell viper venom induced.excess phospholipid.post heparin neutralization


name: Coagulation actual/Normal:RelTime:Pt:PPP:Qn:Coag.dilute Russell viper venom induced.excess phospholipid.post heparin neutralization


name: Coagulation:Time:Pt:PPP:Qn:Coag.dilute Russell viper venom induced.factor substitution.immediately after 1:1 addition of normal plasma+heparin neutralization


name: Columbia - suicide severity rating scale - lifetime recent:-:Pt:^Patient:-:C-SSRS


name: Columbia - suicide severity rating scale - lifetime recent


name: Non-specific active suicidal thoughts:Find:1Mo:^Patient:Ord


name: Active suicidal ideation with any methods (not plan) without intent to act:Find:1Mo:^Patient:Ord


name: Active suicidal ideation with any methods (not plan) without intent to act


name: Active suicidal ideation with some intent to act, without specific plan:Find:1Mo:^Patient:Ord


name: Active suicidal ideation with some intent to act, without specific plan


name: Active suicidal ideation with specific plan and intent:Find:1Mo:^Patient:Ord


name: Active suicidal ideation with specific plan and intent


name: Duration of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Duration of most severe suicidal ideation


name: Duration of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Has subject engaged in non-suicidal self-injurious behavior:Find:Lifetime:^Patient:Ord


name: Has subject engaged in non-suicidal self-injurious behavior


name: Has subject engaged in non-suicidal self-injurious behavior:Find:3Mo:^Patient:Ord


name: Aborted or self-interrupted suicide attempt:Find:Lifetime:^Patient:Ord


name: Aborted or self-interrupted suicide attempts


name: Aborted or self-interrupted suicide attempts:Num:Lifetime:^Patient:Qn


name: Aborted or self-interrupted suicide attempt:Find:3Mo:^Patient:Ord


name: Aborted or self-interrupted suicide attempts:Num:3Mo:^Patient:Qn


name: Preparatory acts or suicidal behavior:Find:Lifetime:^Patient:Ord


name: Preparatory acts or suicidal behaviors:Num:Lifetime:^Patient:Qn


name: Preparatory acts or suicidal behavior:Find:3Mo:^Patient:Ord


name: Preparatory acts or suicidal behaviors:Num:3Mo:^Patient:Ord


name: Actual lethality or medical damage most lethal suicide attempt:Find:Lifetime:^Patient:Ord:C-SSRS


name: Actual lethality or medical damage most lethal suicide attempt


name: Potential lethality most lethal suicide attempt:Find:Lifetime:^Patient:Ord:C-SSRS


name: Potential lethality most lethal suicide attempt


name: Most severe suicidal ideation description:Find:1Mo:^Patient:Nom


name: Most severe suicidal ideation description


name: Most severe suicidal ideation description:Find:Lifetime:^Patient:Nom


name: Potential lethality initial or first suicide attempt:Find:Pt:^Patient:Ord:C-SSRS


name: Potential lethality initial or first suicide attempt


name: Potential lethality most recent suicide attempt:Find:Pt:^Patient:Ord:C-SSRS


name: Potential lethality most recent suicide attempt


name: Actual lethality or medical damage initial or first suicide attempt:Find:Pt:^Patient:Ord:C-SSRS


name: Actual lethality or medical damage initial or first suicide attempt


name: Actual lethality or medical damage most recent suicide attempt:Find:Pt:^Patient:Ord:C-SSRS


name: Actual lethality or medical damage most recent suicide attempt


name: Reasons for most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Reasons for most severe suicidal ideation


name: Reasons for most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Deterrents of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Deterrents of most severe suicidal ideation


name: Deterrents of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Controllability of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Controllability of most severe suicidal ideation


name: Controllability of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Frequency of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS


name: Frequency of most severe suicidal ideation


name: Frequency of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS


name: Most severe suicidal ideation:Type:1Mo:^Patient:Ord


name: Most severe suicidal ideation:Type:Lifetime:^Patient:Ord


name: Active suicidal ideation with specific plan and intent:Find:Lifetime:^Patient:Ord


name: Active suicidal ideation with some intent to act, without specific plan:Find:Lifetime:^Patient:Ord


name: Active suicidal ideation with any methods (not plan) without intent to act:Find:Lifetime:^Patient:Ord


name: Date of initial or first suicide attempt:Date:Pt:^Patient:Qn


name: Date of initial or first suicide attempt


name: Risk of adverse drug reaction sequence variation interpretation:Imp:Pt:Bld/Tiss:Nar


name: Risk of adverse drug reaction sequence variation interpretation


name: Hearing.ability to hear during 3D assessment period:Find:3D:^Patient:Ord:CMS Assessment


name: Hearing.ability to hear during 3D assessment period


name: Vision.ability to see in adequate light during 3D assessment period:Find:3D:^Patient:Ord:CMS Assessment


name: Vision.ability to see in adequate light during 3D assessment period


name: Platelet glycoprotein disorder:Imp:Pt:Bld:Nar:Flow cytometry


name: Platelet glycoprotein VI actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD49b actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD42b actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD42a actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD61 actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet CD41 actual/normal:RelRto:Pt:Bld:Qn:Flow cytometry


name: Platelet glycoprotein disorder panel:-:Pt:Bld:Qn:Flow cytometry


name: Thrombospondin type I domain-containing 7A Ab.IgG:PrThr:Pt:Ser/Plas:Ord:IF


name: Power level^peak during exercise:EngRat:Pt:^Patient:Qn


name: Treatment to which interaction between genetic variants confers synergy:Prid:Pt:Bld/Tiss:Nom


name: Treatment to which interaction between genetic variants confers synergy


name: Treatment to which genetic variant confers resistance:Prid:Pt:Bld/Tiss:Nom


name: Treatment to which genetic variant confers resistance


name: Genetic variant effect on drug resistance:Find:Pt:Bld/Tiss:Nar


name: Genetic variant effect on drug resistance


name: Genetic variant effect on drug sensitivity:Find:Pt:Bld/Tiss:Nar


name: Genetic variant effect on drug sensitivity


name: Available treatment related to genetic variant and not to patient diagnosis:Prid:Pt:Bld/Tiss:Nom


name: Available treatment related to genetic variant and not to patient diagnosis


name: Available treatment related to genetic variant and to patient diagnosis:Prid:Pt:Bld/Tiss:Nom


name: Available treatment related to genetic variant and to patient diagnosis


name: Treatment to which interaction between genetic variants confers resistance:Prid:Pt:Bld/Tiss:Nom


name: Treatment to which interaction between genetic variants confers resistance


name: Neutrophil CD64 & Monocyte HLA DR panel:-:Pt:Bld:Qn:Flow cytometry


name: Monotypic plasma cell identification & risk stratification panel:-:Pt:Bone mar:-:Molgen


name: Monotypic plasma cell identification & risk stratification panel


name: Plasma cells.polyclonal/Cells counted:NFr:Pt:Bone mar:Qn:Flow cytometry


name: Monotypic plasma cell DNA ploidy:Type:Pt:Bone mar:Nom:Flow cytometry


name: Monotypic plasma cell DNA index:Ratio:Pt:Bone mar:Qn:Flow cytometry


name: Plasma cells.monotypic.S phase/Cells:NFr:Pt:Bone mar:Qn:Flow cytometry


name: Plasma cells.monotypic population:Prid:Pt:Bone mar:Nom:Flow cytometry


name: Plasma cell DNA content & proliferation panel:-:Pt:Bone mar:-:Flow cytometry


name: Plasma cell DNA content & proliferation panel


name: Genetic variant diagnostic significance:Imp:Pt:Bld/Tiss:Nar


name: Genetic variant prognostic significance:Imp:Pt:Bld/Tiss:Nar


name: Gene studied with no variant found:Prid:Pt:Bld/Tiss:Nom


name: Variant of unknown significance:Prid:Pt:Bld/Tiss:Nom


name: Summary of interaction between genetic variants:Imp:Pt:Bld/Tiss:Nar


name: Summary of interaction between genetic variants


name: Krebs von den Lungen-6:ACnc:Pt:Ser/Plas:Qn:IA


name: Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel:-:Pt:Ser:-


name: Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel


name: von Willebrand factor cleaving protease activity:CCnc:Pt:PPP:Qn:Chromo


name: Indexing - national clinical trial number:-:-:^FDA product label:Nar


name: Indexing - national clinical trial number


name: Columbia - suicide severity rating scale screener - recent:-:Pt:^Patient:-:C-SSRS


name: Columbia - suicide severity rating scale screener - recent


name: Serratia sp DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Salmonella sp DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Pseudomonas aeruginosa DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Proteus mirabilis DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Neisseria meningitidis DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Gram positive bacteria DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Bacterial carbapenem resistance blaOXA-23-like+blaOXA-48-like genes:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Stenotrophomonas maltophilia DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Serratia marcescens DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Proteus sp DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Morganella morganii DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Klebsiella pneumoniae DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Fusobacterium nucleatum DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Haemophilus influenzae DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Klebsiella oxytoca DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Fusobacterium necrophorum DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Escherichia coli DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Cronobacter sakazakii DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Citrobacter sp DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Enterobacter cloacae complex DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Bacteroides fragilis DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Acinetobacter baumannii DNA:PrThr:Pt:Bld.pos growth:Ord:Probe.amp.tar


name: Gram negative blood culture panel:-:Pt:Bld.pos growth:-:Probe.amp.tar


name: Platelet aggregation:RelACnc:Pt:PRP:Qn:Aggregometry.epinephrine induced.10 umol/L


name: Platelet aggregation:RelACnc:Pt:PRP:Qn:Aggregometry.epinephrine induced.5 umol/L


name: Platelet aggregation:RelACnc:Pt:PRP:Qn:Aggregometry.ristocetin induced.5 ug/mL


name: COMT gene product metabolic activity interpretation:Imp:Pt:Bld/Tiss:Ord:Molgen


name: COMT gene product metabolic activity interpretation


name: SLCO1B1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Mechanical circulatory support+consultation note:Find:Pt:{Setting}:Doc:{Role}


name: Mechanical circulatory support+consultation note


name: Deprecated Disorganized thinking in last 3 days [CMS Assessment]


name: Deprecated Inattention in last 3 days [CMS Assessment]


name: IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM):-:3D:^Patient:-:CMS Assessment


name: IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM)


name: Alpha 1 antitrypsin fecal clearance panel:-:Pt:Ser/Plas+Stool:Qn


name: Alpha 1 antitrypsin fecal clearance panel


name: APOA1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Glial fibrillary acidic protein.alpha subunit Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Glial fibrillary acidic protein.alpha subunit Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Glial fibrillary acidic protein.alpha subunit Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Glial fibrillary acidic protein.alpha subunit Ab.IgG:PrThr:Pt:Ser:Ord:CBA IFA


name: Gamma aminobutyrate B receptor Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: Gamma aminobutyrate B receptor Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Gamma aminobutyrate B receptor Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:IF


name: Gamma aminobutyrate B receptor Ab.IgG:PrThr:Pt:Ser/Plas:Ord:CBA IFA


name: Busulfan^4H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^2H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^1H post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Busulfan^immediately post busulfan infusion completion:MCnc:Pt:Plas:Qn


name: Herpes Simplex Virus 2 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Herpes Simplex Virus 1 DNA:PrThr:Pt:Bld:Ord:Non-probe.amp.tar


name: Herpes Simplex Virus 1 & 2 DNA Panel:-:Pt:Bld:-:Non-probe.amp.tar


name: Coagulation factor VIII Inhibitor:ACnc:Pt:PPP:Qn:Chromo


name: Busulfan area under the curve panel:-:Stdy:Plas:Qn


name: Cortisol post corticotropin releasing hormone stimulation panel:-:Pt:Ser/Plas:Qn


name: Cortisol post corticotropin releasing hormone stimulation panel


name: Cortisol^10M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^1M pre 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^2M post 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Cortisol^5M pre 1 ug/kg CRH IV:MCnc:Pt:Ser/Plas:Qn


name: Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent:-:Pt:^Patient:-:C-SSRS


name: Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent


name: Has subject engaged in self-injurious behavior, intent unknown:Find:3Mo:^Patient:Ord


name: Has subject engaged in self-injurious behavior, intent unknown


name: Has subject engaged in self-injurious behavior, intent unknown:Find:Lifetime:^Patient:Ord


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG:PrThr:Pt:Ser/Plas:Ord:CBA IFA


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:IF


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Ab.IgG:ACnc:Pt:Ser:Qn:IA


name: Moxifloxacin:Susc:Pt:Isolate:OrdQn:Method for Slow-growing mycobacteria.antibiotic concentration at 3.0 ug/mL


name: Metabotropic glutamate receptor 1 Ab.IgG:PrThr:Pt:Ser:Ord:CBA IFA


name: Metabotropic glutamate receptor 1 Ab.IgG:Titr:Pt:Ser:SemiQn:IF


name: Metabotropic glutamate receptor 1 Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: Metabotropic glutamate receptor 1 Ab.IgG:Titr:Pt:CSF:SemiQn:IF


name: N-methyl-D-aspartate receptor subunit 1 Ab.IgG:PrThr:Pt:CSF:Ord:CBA IFA


name: N-methyl-D-aspartate receptor subunit 1 Ab.IgG:PrThr:Pt:Ser:Ord:CBA IFA


name: Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel:-:Pt:Ser:-


name: Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel


name: Frequency of most severe suicidal ideation:Find:1Mo:^Patient:Ord:C-SSRS.PCI


name: Frequency of most severe suicidal ideation:Find:Lifetime:^Patient:Ord:C-SSRS.PCI


name: Multisection^WO & W contrast IV:Find:Pt:Head & Neck>Spine.cervical:Doc:CT


name: Multisection:Find:Pt:Lower extremity.bilateral>Lower extremity arteries+Lower extremity veins:Doc:US.doppler


name: Views 2 or 3:Find:Pt:Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:XR


name: Views 4 or 5:Find:Pt:Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:XR


name: Views GE 6:Find:Pt:Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccyx:Doc:XR


name: Atrial contraction strain rate.max:ARat:Pt:Heart.ventricle.left:Qn:US.3D


name: Atrial contraction strain rate.circumferential.max:LenRto:Pt:Heart.ventricle.left:Qn:US.3D


name: Atrial contraction strain rate.circumferential.max


name: Atrial contraction strain rate.longitudinal.max:ARat:Pt:Heart.ventricle.left:Qn:US.3D


name: Atrial contraction strain rate.longitudinal.max


name: Circumferential strain rate.early diastole.max:ARat:Pt:Heart.ventricle.left:Qn:US.3D


name: Longitudinal strain rate.early diastole.max:ARat:Pt:Heart.ventricle.left:Qn:US.3D


name: Regurgitant volume:Vol:Pt:Tricuspid valve:Qn:US.doppler+Calculated by PISA method


name: Blood flow reversal.systolic:Find:Pt:Hepatic vein:Ord:US.doppler


name: Regurgitant blood velocity-time integral:Len:Pt:Tricuspid valve:Qn:US.doppler


name: Regurgitant blood velocity-time integral


name: Regurgitant orifice area:Area:Pt:Tricuspid valve:Qn:US.doppler.color


name: Blood flow reversal.diastolic:Find:Pt:Pulmonary artery.main:Ord:US.doppler


name: Pressure gradient.early diastole.max:PressDiff:Pt:Pulmonic valve:Qn:US.doppler


name: Regurgitant blood flow velocity.early diastole:Vel:Pt:Pulmonary valve:Qn:US.doppler.PW


name: Regurgitant blood flow velocity.early diastole


name: Blood flow velocity.S2 wave:Vel:Pt:Pulmonary vein:Qn:US.doppler.PW


name: Blood flow velocity.S1 wave:Vel:Pt:Pulmonary vein:Qn:US.doppler.PW


name: Regurgitant blood velocity-time integral:Len:Pt:Mitral valve:Qn:US.doppler


name: Regurgitant fraction:VFr:Pt:Aortic valve:Qn:US.doppler+Calculated by PISA method


name: Regurgitant blood velocity-time integral:Len:Pt:Aortic valve:Qn:US.doppler


name: Velocity-time integral.left ventricular outflow tract/velocity-time integral.aortic valve:LenRto:Pt:Heart:Qn:US.doppler


name: Velocity-time integral.left ventricular outflow tract/velocity-time integral.aortic valve


name: Blood flow velocity.max.left ventricular outflow tract/blood flow.max.aortic valve:VelRto:Pt:Heart:Qn:US.doppler


name: Blood flow velocity.max.left ventricular outflow tract/blood flow.max.aortic valve


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D.A2C+Calc by single plane method of disks


name: End-systolic volume/Body surface area:ArVol:Pt:Heart.atrium.left:Qn:US.2D.A4C+Calc by single plane method of disks


name: End-systolic volume:Vol:Pt:Heart.atrium.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: End-systolic volume:Vol:Pt:Heart.atrium.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: Ejection fraction:VFr:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane method of disks


name: Cardiac output:VRat:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane method of disks


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane method of disks


name: Stroke volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane method of disks


name: End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: End-systolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A2C+Calc by single plane area-length method


name: End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D.A4C+Calc by single plane area-length method


name: End-diastolic volume:Vol:Pt:Heart.ventricle.left:Qn:US.2D+Calculated by biplane area-length method


name: Regurgitant blood flow pressure half-time:Time:Pt:Pulmonary valve:Qn:US.doppler


name: Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2M:Find:2M:^Patient:Ord:WellRx


name: Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2M


name: Are you homeless or worried that you might be in the future:Find:Pt:^Patient:Ord:WellRx


name: Are you homeless or worried that you might be in the future


name: Do you have trouble paying for your gas or electricity bills:Find:Pt:^Patient:Ord:WellRx


name: Do you have trouble paying for your gas or electricity bills


name: Do you have trouble finding or paying for transportation:Find:Pt:^Patient:Ord:WellRx


name: Do you have trouble finding or paying for transportation


name: Do you need daycare, or better daycare, for your kids:Find:Pt:^Patient:Ord:WellRx


name: Do you need daycare, or better daycare, for your kids


name: Are you unemployed or without regular income:Find:Pt:^Patient:Ord:WellRx


name: Are you unemployed or without regular income


name: Do you need help finding a better job:Find:Pt:^Patient:Ord:WellRx


name: Do you need help getting more education:Find:Pt:^Patient:Ord:WellRx


name: Are you concerned about someone in your home using drugs or alcohol:Find:Pt:^Patient:Ord:WellRx


name: Are you concerned about someone in your home using drugs or alcohol


name: Do you need help with legal issues:Find:Pt:^Patient:Ord


name: Have you been at the emergency department more than twice in the last 6Mo:Find:6Mo:^Patient:Ord:WellRx


name: Have you been at the emergency department more than twice in the last 6Mo


name: Emergency department visits in last 6Mo:Num:6Mo:^Patient:Qn


name: Hospitalized in the last 6Mo:Find:6Mo:^Patient:Ord


name: Number of times hospitalized in last 6Mo:Num:6Mo:^Patient:Qn


name: Number of times hospitalized in last 6 months


name: Do you feel unsafe in your daily life:Find:Pt:^Patient:Ord:WellRx


name: Is anyone in your home threatening or abusing you:Find:Pt:^Patient:Ord:WellRx


name: Is anyone in your home threatening or abusing you


name: Gas & CO & electrolytes panel:-:Pt:BldA:Qn


name: Thrombospondin type I domain-containing 7A Ab.IgG:Titr:Pt:Ser/Plas:SemiQn:CBA IFA


name: Nonalcoholic steatohepatitis & fibrosis panel:-:Pt:Ser/Plas:-


name: Nonalcoholic steatohepatitis & fibrosis panel


name: Gram negative bacterial resistance panel:-:Pt:Isolate/Specimen:-:Molgen


name: Gram negative bacterial resistance panel


name: Bacterial beta-lactam resistance AmpC blaCMY-2 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial beta-lactam resistance AmpC blaDHA gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Bacterial colistin resistance mcr-2 gene:PrThr:Pt:Isolate/Specimen:Ord:Molgen


name: Platelet aggregation:RelACnc:Pt:PRP:Qn:Aggregometry.ristocetin induced.15 ug/mL


name: Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel:-:Pt:Fibroblasts:-


name: Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel


name: Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel:-:Pt:WBC:-


name: Ethyl sulfate & Ethyl glucuronide panel:-:Pt:Urine:-


name: Epstein Barr virus Ab panel:-:Pt:Ser^Donor:-


name: Epstein Barr virus nuclear Ab:PrThr:Pt:Ser^Donor:Ord:IA


name: Epstein Barr virus capsid Ab.IgG:PrThr:Pt:Ser^Donor:Ord:IA


name: Epstein Barr virus capsid Ab.IgM:PrThr:Pt:Ser^Donor:Ord:IA


name: Francisella tularensis Ab.IgG & IgM panel:-:Pt:Ser:-


name: Francisella tularensis Ab.IgG & IgM panel


name: Francisella tularensis Ab.IgG & IgM:Imp:Pt:Ser:Nom


name: Indexing - drug interactions:-:-:^FDA product label:Nar


name: Brassica oleracea var gongylodes Ab.IgE:ACnc:Pt:Ser:Qn


name: Brassica oleracea var botrytis cooked Ab.IgE:ACnc:Pt:Ser:Qn


name: Brassica oleracea var capitata f rubra Ab.IgE:ACnc:Pt:Ser:Qn


name: HTLV I & II Ab band pattern:Imp:Pt:CSF:Nom:Line blot


name: HTLV I & II Ab.IgG band:Type:Pt:CSF:Nom:Line blot


name: HTLV I+II Ab.IgG:PrThr:Pt:CSF:Ord:Line blot


name: Parainfluenza virus 1+2+3+4 Ab.IgG:PrThr:Pt:Ser:Ord:IA


name: Mumps virus N gene:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Mumps virus RNA & N gene panel:-:Pt:XXX:-


name: Atypical porcine pestivirus RNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Atypical porcine pestivirus RNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Porcine circovirus type 3 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Mycoplasma hyorhinis Ab.IgG/Positive control:RelRto:Pt:Ser:Qn:IA


name: Mycoplasma hyorhinis Ab.IgG/Positive control


name: Salmonella choleraesuis+infantis+typhimurium Ab/Positive control:RelRto:Pt:XXX:Qn:IA


name: Salmonella choleraesuis+infantis+typhimurium Ab/Positive control


name: Influenza virus A PB2 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A PB1 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A PA gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A NP gene:Seq:Pt:Isolate:Nom:Sequencing


name: Influenza virus A NS1 gene:Seq:Pt:Isolate:Nom:Sequencing


name: Porcine astrovirus type 3 RNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Human papilloma virus 16+18 E6+E7 mRNA:PrThr:Pt:Tiss:Ord:Probe


name: Human papilloma virus 6+11 E6+E7 mRNA:PrThr:Pt:Tiss:Ord:Probe


name: Large B-cell lymphoma and cell of origin:Type:Pt:Tiss:Nom


name: Primary mediastinal large B-cell lymphoma:Likelihood:Pt:Tiss:Qn


name: Diffuse large B-cell lymphoma.activated B-cell subtype:Likelihood:Pt:Tiss:Qn


name: Diffuse large B-cell lymphoma cell of origin:Type:Pt:Tiss:Nom


name: Diffuse large B-Cell lymphoma cell of origin subclassification panel:-:Pt:Tiss:-


name: Diffuse large B-Cell lymphoma cell of origin subclassification panel


name: Large B-cell lymphoma classification panel:-:Pt:Tiss:-


name: Large B-cell lymphoma classification panel


name: Varicella zoster virus Ab.IgM+total:PrThr:Pt:CSF:Ord


name: Lymphocytic choriomeningitis virus Ab.IgG+IgM:PrThr:Pt:CSF:Ord


name: F5 gene HR2 haplotype:Geno:Pt:Bld:Nom:Molgen


name: Time to microorganism growth detection:Time:*:Specimen:Qn


name: Glucose tolerance & insulin sensitivity 2H panel:-:-:Ser/Plas:-


name: Glucose tolerance & insulin sensitivity 2H panel


name: MYCN gene copy number/Chromosome 2 copy number:NRto:Pt:Tiss:Qn:FISH


name: MYCN gene copy number/Chromosome 2 copy number


name: MYCN gene copy number/nucleus:EntNum:Pt:Tiss:Qn:FISH


name: Chromosome 2 copy number/nucleus:EntNum:Pt:Tiss:Qn:FISH


name: 1p chromosome deletion/1q chromosome deletion:NRto:Pt:Tiss:Qn:FISH


name: 1p chromosome deletion/1q chromosome deletion


name: 19q chromosome deletion/19p chromosome deletion:NRto:Pt:Tiss:Qn:FISH


name: Chromosome 12 copy number/nucleus:EntNum:Pt:Tiss:Qn:FISH


name: MDM2 gene copy number/nucleus:EntNum:Pt:Tiss:Qn:FISH


name: MDM2 gene copy number/Chromosome 12 copy number:NRto:Pt:Tiss:Qn:FISH


name: MDM2 gene copy number/Chromosome 12 copy number


name: F9 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: NTRK1 gene & NTRK2 gene & NTRK3 gene rearrangements:Find:Pt:Tiss:Doc:Molgen


name: SERPINC1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: PROC gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Calories burned^during weight training:EngRat:XXX:^Patient:Qn


name: Calories burned^during aerobic activity:EngRat:XXX:^Patient:Qn


name: Calories burned^while playing a sport:EngRat:XXX:^Patient:Qn


name: Epstein Barr virus DNA:ACnc:Pt:Bld:Qn:Probe.amp.tar


name: Epstein Barr virus DNA:LaCnc:Pt:Bld:Qn:Probe.amp.tar


name: HOGA1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Primary hyperoxaluria multigene analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Primary hyperoxaluria multigene analysis


name: UGT1A1 gene full mutation analysis:Find:Pt:Bld/Tiss:Doc:Sequencing


name: Toxoplasma gondii Ab.IgG panel:-:Pt:Ser^Donor:-


name: Gamma aminobutyrate B receptor Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: N-methyl-D-aspartate receptor subunit 1 Ab:PrThr:Pt:Ser:Ord:CBA IFA


name: Methane/Expired gas^2H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^1.5H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^1H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^45M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^30M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^15M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^pre dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Methane/Expired gas^post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Progress note:Find:Pt:{Setting}:Doc:Maternal and fetal medicine


name: Plan of care note:Find:Pt:{Setting}:Doc:Healthcare navigator


name: Discharge summary note:Find:Pt:{Setting}:Doc:Healthcare navigator


name: ABO & Rh group^during infancy:Type:Pt:Bld:Nom


name: A little u super little b Ag:PrThr:Pt:RBC:Ord


name: K Ag^post transfusion reaction:PrThr:Pt:RBC:Ord


name: Rh antigens & K Ag post transfusion reaction panel:-:Pt:Bld:-


name: Rh antigens & K Ag post transfusion reaction panel


name: ABO & Rh group post transfusion reaction panel:-:Pt:Bld:-


name: ABO & Rh group post transfusion reaction panel


name: K Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: Rh antigens & K Ag post hematopoietic stem cell transplant panel:-:Pt:Bld:-


name: Rh antigens & K Ag post hematopoietic stem cell transplant panel


name: D Ag^post hematopoietic stem cell transplant:PrThr:Pt:RBC:Ord


name: ABO group^post hematopoietic stem cell transplant:Type:Pt:Bld:Nom


name: ABO & Rh group^post hematopoietic stem cell transplant:Type:Pt:Bld:Nom


name: ABO & Rh group post hematopoietic stem cell transplant panel:-:Pt:Bld:-


name: ABO & Rh group post hematopoietic stem cell transplant panel


name: Rh antigens & K Ag during infancy panel:-:Pt:Bld:-


name: ABO & Rh group during infancy panel:-:Pt:Bld:-


name: Note:Find:Pt:Outpatient:Doc:Wound, ostomy, and continence care


name: Consultation note:Find:Pt:{Setting}:Doc:Wound, ostomy, and continence care


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Developmental-behavioral pediatrics


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Eating disorders


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Heart failure+Transplant cardiology


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Integrative medicine


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Physical medicine and rehab


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Plastic surgery


name: Diagnostic study note:Find:Pt:{Setting}:Doc:Wound, ostomy, and continence care


name: Chikungunya virus Ab.IgM & IgG panel:-:Pt:Ser/Plas:-


name: Hydrogen/Expired gas^2H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^1.5H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^1H post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^45M post dose carbohydrate:VFr:Pt:Exhl gas:Qn


name: Hydrogen/Expired gas^30M post dose carbohydrate:VFr:Pt:Exhl gas:Qn